Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Updates in Advances in Lung Cancer PDF full book. Access full book title Updates in Advances in Lung Cancer by Joan H. Schiller. Download full books in PDF and EPUB format.
Author: Joan H. Schiller Publisher: Karger Medical and Scientific Publishers ISBN: 9783805565578 Category : Medical Languages : en Pages : 202
Book Description
Lung cancer remains a major cause of cancer deaths throughout the world. It is an extremely lethal neoplasm: 80-90% of patients who develop lung cancer will die of their disease. The purpose of this book is to update cancer specialists, pulmonary physicians, thoracic surgeons and general practitioners about the many recent advances in the treatment, prevention and biology of lung cancer. Despite the overall poor prognosis for patients, a number of new chemotherapeutic drugs and regimens have been developed which result in a clinically meaningful improvement in survival for patients with nonsmall cell lung carcinoma. Four chapters in this book are devoted to reviewing these new drugs and drug combinations (paclitaxel, docetaxel, vinorelbine, gemcitabine, topoisomerase inhibitors). Advances in the management of locally advanced nonsmall cell and small cell lung cancer are considered, including combined-modality treatments using chemotherapy, surgery, and radiation therapy. Results of recent trials involving chemoprevention agents are also reported. Finally, the latest progress in understanding the molecular biology of this disease, and how it might impact on the clinical management of lung cancer patients, is discussed.
Author: Joan H. Schiller Publisher: Karger Medical and Scientific Publishers ISBN: 9783805565578 Category : Medical Languages : en Pages : 202
Book Description
Lung cancer remains a major cause of cancer deaths throughout the world. It is an extremely lethal neoplasm: 80-90% of patients who develop lung cancer will die of their disease. The purpose of this book is to update cancer specialists, pulmonary physicians, thoracic surgeons and general practitioners about the many recent advances in the treatment, prevention and biology of lung cancer. Despite the overall poor prognosis for patients, a number of new chemotherapeutic drugs and regimens have been developed which result in a clinically meaningful improvement in survival for patients with nonsmall cell lung carcinoma. Four chapters in this book are devoted to reviewing these new drugs and drug combinations (paclitaxel, docetaxel, vinorelbine, gemcitabine, topoisomerase inhibitors). Advances in the management of locally advanced nonsmall cell and small cell lung cancer are considered, including combined-modality treatments using chemotherapy, surgery, and radiation therapy. Results of recent trials involving chemoprevention agents are also reported. Finally, the latest progress in understanding the molecular biology of this disease, and how it might impact on the clinical management of lung cancer patients, is discussed.
Author: Karen L. Reckamp Publisher: Springer ISBN: 3319403893 Category : Medical Languages : en Pages : 322
Book Description
This book describes the molecular mechanisms of lung cancer development and progression that determine therapeutic interventions in the era of genomics, when the rapid evolution in lung cancer diagnosis and treatment necessitates critical review of new results to integrate advances into practice. The text opens with background and emerging information regarding the molecular biology of lung cancer pathogenesis. Updated results regarding lung cancer prevention and screening are discussed, followed by chapters on diagnostic techniques and pathological evaluation. This leads on to a detailed presentation of treatment modalities, from surgery and radiation therapy to standard chemotherapy and targeted agents. The coverage includes resistance to therapy and the emergence of immunotherapy for lung cancer; in addition, the current evidence in respect of small cell lung cancer is summarized. The book presents insights from experts across disciplines to emphasize the importance of collaborative care. Advances in our understanding of issues in geriatric oncology and palliative care complete the comprehensive discussion of lung cancer.
Author: Branislav Jeremic Publisher: Springer Science & Business Media ISBN: 3642199259 Category : Medical Languages : en Pages : 843
Book Description
This is the second, completely updated edition of a comprehensive book in which many of the world’s leading lung cancer specialists discuss the recent advances in the radiation oncology of lung cancer and reflect on the latest research findings. The first three sections cover the basic science of lung cancer, clinical investigations, including histology and staging, and a wide range of fundamental treatment considerations. Current treatment strategies for small cell and non-small cell lung cancer are then explained and evaluated in detail, with due attention to novel approaches that promise further improvements in outcome. The various types of treatment-related toxicity are discussed, and quality of life studies and prognostic factors are also considered. After evaluating the latest technological and biological advances, including IMRT, IMAT, cyber knife treatment, and tomotherapy, the book concludes by thorough consideration of specific aspects of clinical research in lung cancer.
Author: Aamir Ahmad Publisher: Springer ISBN: 3319242237 Category : Medical Languages : en Pages : 228
Book Description
This, the first of two volumes on personalized medicine in lung cancer, touches on the core issues related to the understanding of lung cancer—statistics and epidemiology of lung cancer—along with the incidence of lung cancer in non-smokers. A major focus of this volume is the state of current therapies against lung cancer—immune, targeted therapies against EGFR TKIs, KRAS, ALK, angiogenesis; the associated challenges, especially resistance mechanisms; and recent progress in targeted drug development based on metal chemistry. Chapters are written by some of the leading experts in the field, who provide a better understanding of lung cancer, the factors that make it lethal, and current research focused on developing personalized treatment plans. With a unique mix of topics, this volume summarizes the current state-of-knowledge on lung cancer and the available therapies.
Author: Jack A. Roth Publisher: John Wiley & Sons ISBN: 1118468775 Category : Medical Languages : en Pages : 616
Book Description
The best and most concise single source for state-of-the-artdiagnosis and treatment of lung cancer –newly revised,updated, and expanded. Lung cancer has long been the number-one cause of death from cancerevery year and the third most frequently diagnosed after breast andprostate cancers. In 2010, about 15% of all cancer diagnoses and30% of all cancer deaths were due to lung cancer. Needless to say,there is a great need for more rapid advancements in diagnosis andtreatment of this devastating disease. Here is the comprehensively revised, updated, and expandededition of the well-established, evidence-based reference book thatdeals with the most recent advances in lung cancer prevention,screening, diagnosis, research, and treatment for the clinician.Edited and authored by leading authorities in the field, thisFourth Edition of the highly regarded Lung Cancer is betterthan ever –featuring nine new chapters along with sevenre-formatted ones that are nearly brand new in content andapproach. It covers Smoking Prevention and Cessation; MolecularProfiling; Somatic Genome Alterations in Human Lung Cancers;Management of Multi-Focal Bronchioloalveolar Carcinoma (BAC);Primary Tracheal Tumors; Predictive Tumor Biomarkers for EGFRInhibitors; Non-Small Cell and Small-Cell Lung Carcinoma; andmore. This Fourth Edition of Lung Cancer: Provides the very latest research in the identification ofbiomarkers to predict a high risk for developing lung cancer– vital for implementing screening, diagnosis, and preventionstrategies Presents the newest lung cancer staging system, as well asupdated and cutting-edge surgical and radiation therapy techniquesthat make local tumor control more effective and less invasivewhile sparing normal tissues Discusses combined modality therapy and new chemotherapeuticagents which are yielding higher response rates and improvedsurvival when used in the adjuvant setting or concurrent withhighly sophisticated radiation or proton treatment Offers novel and emergent approaches to preventative,diagnostic, and therapeutic modalities with an emphasis on the bestevidence available from the latest studies and clinical trials With almost half of the revised and updated content being brandnew, Lung Cancer, Fourth Edition, is an important and vitalresource for all medical professionals and students involved in thecare and treatment of those struck with this catastrophicillness.
Author: Vera Hirsh Publisher: Frontiers Media SA ISBN: 2889453979 Category : Languages : en Pages : 95
Book Description
Lung cancer remains a major cause of death in of both women and men in our society. Lung cancer treatment paradigms have changed enormously as we’ve started to understand the genetic complexity and the multiple driver mutations influencing the disease. Therapeutics directed towards, or to inhibit signaling pathways has resulted in increased life spans for our patients. Over the last two decades, we have gone from simple chemotherapy used to treat all, to a personalized medicine approach for the majority. For non-small cell lung cancer patients without driver mutations, the world of immune oncology has arrived. These improved long-term outcomes mean that now our lung cancer patients can live with their cancers, but without progression. The aim of this book is to catalogue the current state of knowledge for the many facets of advanced lung cancer. It describes current treatment approaches for driver mutations, rare mutations, and rare thoracic malignancies such as neuroendocrine tumors. Most importantly, this book addresses the topics of palliative treatment and care which allow our patients to enjoy longer survival with the highest quality of life. We hope you enjoy this e-book. The future is brighter for lung cancer patients and as lung cancer specialists; we finally feel sense optimism about treatment options for our patients.
Author: Branislav Jeremic Publisher: Springer Science & Business Media ISBN: 3540266321 Category : Medical Languages : en Pages : 510
Book Description
Although decades of laboratory and clinical research have led to incremental improvement in treatment outcome, lung cancer remains one of the most deadly diseases. This volume is unique in being devoted solely to the radiation oncology of lung cancer, and will be of great value to all who are involved in the diagnosis and treatment of the disease. Both non-small cell and small cell lung cancer are considered in detail. Current state-of-the-art treatment strategies and novel approaches that promise further improvements in outcome are explained and evaluated, with the aid of high-quality illustrations. Treatment-related toxicity is discussed, and further individual chapters focus on topics such as quality of life studies, prognostic factors and pitfalls in the design and analysis of clinical trials.
Author: Heine H. Hansen Publisher: Springer Science & Business Media ISBN: 1461526302 Category : Medical Languages : en Pages : 410
Book Description
Primary lung tumors are now a global health problem. The incidence has risen dramatically during the last 5--6 decades, reflecting the popularity of cigarette smoking. In this, the fifth volume dealing with lung cancer in the series KappaCANCER TREATMENT AND RESEARCHkappa, many current research topics are covered by notable authorities, including chemoprevention, growth factors, multidrug resistance, new agents, and haematopoietic growth factors. Altogether, the 17 chapters from twelve countries highlight some of the rapid developments taking place in basic and clinical research of lung cancer. These chapters not only give up-to-date information, they will also stimulate further research into this man-made disease which was almost unheard of a century ago.
Author: W. H. O. Classification WHO Classification of Tumours Editorial Board Publisher: ISBN: 9789283245063 Category : Languages : en Pages : 500
Book Description
****When not purchasing directly from the official sales agents of the WHO, especially at online bookshops, please note that there have been issues with counterfeited copies. Buy only from known sellers and if there are quality issues, please contact the seller for a refund.***** Thoracic Tumoursis the fifth available volume in the fifth edition of the WHO series on the classification of human tumours. This series (also known as the WHO Blue Books) is regarded as the gold standard for the diagnosis of tumours and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise reference books provide indispensable international standards for anyone involved in the care of patients with cancer or in cancer research, underpinning individual patient treatment as well as research into all aspects of cancer causation, prevention, therapy, and education. What's new in this edition? The fifth edition, guided by the WHO Classification of Tumours Editorial Board, establishes a single coherent cancer classification presented across a collection of individual volumes organized on the basis of anatomical site (digestive system, breast, soft tissue and bone, etc.) and structured in a systematic manner, with each tumour type listed within a taxonomic classification: site, category, family (class), type, and subtype. In each volume, the entities are now listed from benign to malignant and are described under an updated set of headings, including histopathology, diagnostic molecular pathology, staging, and easy-to-read essential and desirable diagnostic criteria. Who should read this book? * Pathologists * Oncologists * Respiratory physicians * Thoracic radiologists * Cancer researchers * Surgeons * Epidemiologists * Cancer registrars This volume: * Prepared by 217 authors and editors * Contributors from around the world * More than 1000 high-quality images * More than 3500 references
Author: Jeffrey Y.C. Wong Publisher: Springer ISBN: 3319532359 Category : Medical Languages : en Pages : 271
Book Description
This book concisely reviews important advances in radiation oncology, providing practicing radiation oncologists with a fundamental understanding of each topic and an appreciation of its significance for the future of radiation oncology. It explores in detail the impact of newer imaging modalities, such as multiparametric magnetic resonance imaging (MRI) and positron emission tomography (PET) using fluorodeoxyglucose (FDG) and other novel agents, which deliver improved visualization of the physiologic and phenotypic features of a given cancer, helping oncologists to provide more targeted radiotherapy and assess the response. Due consideration is also given to how advanced technologies for radiation therapy delivery have created new treatment options for patients with localized and metastatic disease, highlighting the increasingly important role of image-guided radiotherapy in treating systemic and oligometastatic disease. Further topics include the potential value of radiotherapy in enhancing immunotherapy thanks to the broader immune-stimulatory effects, how cancer stem cells and the tumor microenvironment influence response, and the application of mathematical and systems biology methods to radiotherapy.
Author: Joan H. Schiller
Author: Joan H. Schiller
Author: Karen L. Reckamp
Author: Branislav Jeremic
Author: Aamir Ahmad
Author: Jack A. Roth
Author: Vera Hirsh
Author: Branislav Jeremic
Author: Heine H. Hansen
Author: W. H. O. Classification WHO Classification of Tumours Editorial Board
Author: Jeffrey Y.C. Wong